Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed <i>IDH1</i> mutant AML

Samantha Nier, Jana Pelouchova, Ralph Hills, Sam Salek, Hélène Derrien, Stéphanie Chatin, Anne-Marie De La Bigne, Susana Vives, Christian Recher, Hartmut Döhner, Adriano Venditti, Paresh Vyas

Open source

DOI: 10.1080/14796694.2025.2587002
Published: 2025-11-19
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2025.2587002,
  title = {Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed
                    <i>IDH1</i>
                    mutant AML},
  author = {Samantha Nier and Jana Pelouchova and Ralph Hills and Sam Salek and Hélène Derrien and Stéphanie Chatin and Anne-Marie De La Bigne and Susana Vives and Christian Recher and Hartmut Döhner and Adriano Venditti and Paresh Vyas},
  year = {2025},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2025.2587002},
  url = {https://doi.org/10.1080/14796694.2025.2587002}
}

RIS

TY  - JOUR
TI  - Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed
                    <i>IDH1</i>
                    mutant AML
AU  - Samantha Nier
AU  - Jana Pelouchova
AU  - Ralph Hills
AU  - Sam Salek
AU  - Hélène Derrien
AU  - Stéphanie Chatin
AU  - Anne-Marie De La Bigne
AU  - Susana Vives
AU  - Christian Recher
AU  - Hartmut Döhner
AU  - Adriano Venditti
AU  - Paresh Vyas
PY  - 2025
JO  - Future Oncology
DO  - 10.1080/14796694.2025.2587002
UR  - https://doi.org/10.1080/14796694.2025.2587002
ER  -

APA

Nier, S., Pelouchova, J., Hills, R., Salek, S., Derrien, H., Chatin, S., Bigne, A. D. L., Vives, S., Recher, C., Döhner, H., Venditti, A., & Vyas, P. (2025). Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed <i>IDH1</i> mutant AML. Future Oncology. https://doi.org/10.1080/14796694.2025.2587002

Source records

crossref · retrieved 2026-09-26T19:19:16.570Z